Viswanathan Ravi

CIK 000147938638 companiesTIMONIUM, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001479386

Recent Transactions

50 trades

Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-07-08+11,466→ 11,466 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-07-08−1,000,000→ 2,239,835 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-07-08+2,200→ 6,587 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-07-08−11,466→ 0 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-06-24+1,097→ 4,387 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-06-24+5,733→ 5,733 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-06-24−5,733→ 0 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-06-24−500,000→ 3,239,835 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-03-24+11,467→ 11,467 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-03-24−1,000,000→ 3,739,835 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-03-24−11,467→ 0 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-03-24+2,194→ 3,290 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-02-15−500,000→ 4,739,835 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-02-15+5,732→ 5,732 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-02-15+1,096→ 1,096 total
Other
Duolingo, Inc.$DUOL
Class A Common Stock
2022-02-15−5,732→ 0 total
Conversion
Duolingo, Inc.$DUOL
Class B Common Stock
2022-02-09−5,239,835→ 0 total
Conversion
Duolingo, Inc.$DUOL
Class A Common Stock
2022-02-09+5,239,835→ 5,239,835 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−1,124,301→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−4,349→ 437,706 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−1,177→ 3,279,627 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+49,030→ 3,280,804 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$0.12/sh+181,190→ 442,055 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−437,706→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+1,800,000→ 6,641,634 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−3,279,627→ 0 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−181,190→ 0 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−49,030→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+4,841,634→ 4,841,634 total
Conversion
Elastic N.V.$ESTC
Ordinary Shares
2018-10-10+1,528,117→ 1,528,117 total
Conversion
Elastic N.V.$ESTC
Ordinary Shares
2018-10-10+4,155,995→ 4,155,995 total
Conversion
Elastic N.V.$ESTC
Series C Convertible Preference Shares
2018-10-10−4,155,995→ 0 total
Conversion
Elastic N.V.$ESTC
Series D Convertible Preference Shares
2018-10-10−1,528,117→ 0 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-09-07$1.67/sh+3,000,000→ 82,978,668 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-09-07$1.67/sh+12,000,000→ 12,000,000 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-08-21$2.26/sh+663,716→ 18,698,038 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-07-19$2.00/sh+50,600→ 18,034,322 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-07-18$1.95/sh+200,000→ 17,983,722 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-06-28$2.10/sh+187,130→ 17,783,722 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-06-27$2.15/sh+5,295→ 17,596,592 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-30$2.15/sh+275→ 17,591,297 total
Award
ARDELYX, INC.$ARDX
Common Stock
2018-05-25$4.00/sh+416,666→ 3,082,186 total
Award
ARDELYX, INC.$ARDX
Common Stock
2018-05-25$4.00/sh+416,667→ 3,082,186 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-21$2.14/sh+32,200→ 17,591,022 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-18$2.14/sh+20,100→ 17,558,822 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-17$2.13/sh+184,179→ 17,538,722 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-08$2.13/sh+70,873→ 17,354,543 total
Disposition from Tender
MULESOFT, INC
Class A Common Stock
2018-05-01−2,576,939→ 0 total
Disposition from Tender
MULESOFT, INC
Class A Common Stock
2018-05-01−12,679,970→ 0 total
Conversion
MULESOFT, INC
Class A Common Stock
2018-05-01+858,978→ 858,978 total

Companies

Recent Filings

Address

1954 GREENSPRING DRIVE SUITE 600

TIMONIUM, MD, 21093

View on SEC.gov